PH-762

· Phio Pharmaceuticals Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PH-762, covering 2026-02-11 to 2026-02-11. Get the full timeline:

Most recent: Clinical Trial Update: Intratumoral PH-762 for Cutaneous Carcinoma [Phase 1]